ResMed Inc.

NYSE:RMD

Medical - Devices

Healthcare
$242.61 +0.85%

+$1.58 today

Market cap
$34.12B
Beta
0.78
P/E (TTM)
18.1
EPS (TTM)
$10.37
Dividend yield
1.28%
52W Low $180.27High $293.81

Volume 1.22M

Average 1.32M

RMD Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

ResMed Inc.NYSE: RMD

Operating Margin · Q4 FY2026 · quarter ended Jun 2026

Operating margin narrows to 30.7%

Operating margin was 30.7% in Q4 FY2026, down 3.1 pp from a year earlier. On a trailing-twelve-month basis it was 33.5%, up 0.7 pp year over year. Over 3 fiscal years it widened by 7.0 pp.

Context

  • Operating margin widened in 3 of the last 3 fiscal years.
  • FY2026 was the highest level in the 4 fiscal years shown.

What to watch

Whether operating margin reaches the consensus estimate from 22 analysts of 37.6% for the fiscal year ending Jun 2027, up from 33.8% in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
30.7%-4.3 pp QoQ
Last fiscal yearJun 2026
33.8%+1.0 pp YoY
LTMJun 2026
33.5%+0.7 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-3.1 pp+0.9 pp+4.0 pp
1 year+1.0 pp+3.8 pp+2.8 pp
3 years+7.0 pp+3.4 pp-3.6 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2026
33.8%
Year-over-year change
+1.0pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How RMD compares with its peers on the latest reported figures

  • RMD's LTM Jun 2026 operating margin of 33.5% is the highest of the 9 companies compared; the peer median is 15.4%.
  • Its year-over-year change of +0.7 pp is the 5th highest of 9, against a peer median of +0.7 pp.
  • Over three fiscal years its change of +7.0 pp compares with a peer median of +4.7 pp.
RMD Competitors Peer median
Operating Margin for RMD and competitors
Company Period LTM level YoY 3-year change
RMDResMed Inc.LTM Jun 202633.5% +0.7 pp+7.0 pp
ISRGIntuitive Surgical, Inc.LTM Sep 202628.4% -0.9 pp+3.9 pp
BSXBoston Scientific CorporationLTM Jun 202621.5% +5.4 pp+5.4 pp
ELMDElectromed, Inc.LTM Mar 202618.5% +4.0 pp+8.3 pp
MDTMedtronic plcLTM Jul 202618.1% +0.2 pp+0.2 pp
GEHCGE HealthCare Technologies Inc.LTM Jun 202612.7% -1.1 pp-0.4 pp
PHGKoninklijke Philips N.V.LTM Jun 20269.7% +3.6 pp+16.6 pp
INSPInspire Medical Systems, Inc.LTM Jun 20266.0% +1.2 pp+17.3 pp
TFXTeleflex IncorporatedLTM Jun 20263.3% -7.2 pp-5.1 pp
Peer median (excluding RMD) 15.4%+0.7 pp+4.7 pp

Competitors are the stored peer set for RMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Revenue3.58B4.22B4.69B5.15B5.65B
Cost of Revenue1.55B1.87B2.03B2.09B2.2B
Gross Profit2.02B2.36B2.66B3.05B3.45B
Gross Margin56.6%55.8%56.7%59.4%61.1%
Research & Development253.58M287.64M307.53M331.28M378.29M
Selling, General & Admin739.37M874M917.14M991.02M1.12B
Operating Expenses1.02B1.22B1.34B1.37B1.54B
Depreciation & Amortization193.84M197.56M216.21M235.81M244.15M
EBITDA1.18B1.36B1.53B1.91B2.15B
EBITDA Margin32.9%32.2%32.7%37.2%38.1%
Operating Income1B1.13B1.32B1.69B1.91B
Operating Margin28.0%26.8%28.2%32.7%33.8%
Interest Income00000
Interest Expense22.31M47.38M45.71M12.61M0
Other Income / Expenses(39.8M)(30.21M)(55.1M)(7.8M)10.96M
Income Before Tax960.48M1.1B1.26B1.68B1.92B
Pre-Tax Margin26.8%26.1%27.0%32.6%34.0%
Income Tax Expense181.05M204.11M243.85M276.84M396.12M
Net Income779.44M897.56M1.02B1.4B1.52B
Net Margin21.8%21.3%21.8%27.2%26.9%
EPS (Basic)5.346.126.949.5510.44
EPS (Diluted)5.306.096.929.5110.40
Weighted Avg Shares146.07M146.77M147.02M146.72M144.71M
Weighted Avg Shares (Diluted)147.04M147.46M147.55M147.34M144.98M

ResMed Inc.

NYSE:RMD

Intrinsic Alpha fair value

Locked

Current Price

$242.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.